(PharmaNewsWire.Com, January 31, 2017 ) According to Publisher, the Global Tuberculosis Diagnostics market is accounted for $2.12 billion in 2015 and is expected to reach $3.12 billion by 2022 growing at a CAGR of 5.6% from 2015 to 2022. Increasing cases of tuberculosis is one of the major factors responsible for high market growth. Furthermore, rising government initiatives, growing requirement of POC in healthcare and increasing geriatric population are some factors that are positively affecting the market. However, lack of awareness among the patients is hindering the market.
Detection of Drug Resistance segment is anticipated to grow at a steady growth rate and exploitation of antibiotics contribute to the high prevalence of drug resistance. Asia Pacific is expected to witness a lucrative growth over the forecast period attributed to rapid proliferation of this disease across the region.
Some of the key players in this market include Hologic Corporation, Cepheid Inc., Siemens AG, Becton, Dickinson and Company, Abbott Laboratories, Hain Lifesciences GmBH, BioMérieux SA, F.Hoffmann-La Roche AG., Alere, Inc., Sanofi, QIAGEN and Thermo Fisher Scientific, Inc.
Test Types Covered: - Detection of Drug Resistance - Detection of Latent Infection - Nucleic Acid Testing - Radiographic Methods - Cytokine Detection Assay - Phage Assay - Diagnostic Laboratory Methods o Culture-Based Test o Smear Microscopy - Other Methods
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
8 Company Profiling 8.1 Hologic Corporation 8.2 Cepheid Inc. 8.3 Siemens AG 8.4 Becton, Dickinson and Company 8.5 Abbott Laboratories 8.6 Hain Lifesciences GmBH 8.7 BioMérieux SA 8.8 F.Hoffmann-La Roche AG 8.9 Alere, Inc. 8.10 Sanofi 8.11 QIAGEN 8.12 Thermo Fisher Scientific, Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
